🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT01619917
Recruiting Not applicable

The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars

NCT01619917 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2012-11-01
Last updated
2026-05-14

Condition(s) studied

Burn Scar

Investigational drug(s) / intervention(s)

Fractional Vascular Laser

Fractional Vascular Laser: laser energy will be applied to one of 2 sites (proximal or distal) depending on randomization result

Study summary

While the literature tends to support the use of laser therapy in the management of burn scars, there is a definite lack of appropriately powered, randomized controlled trials. Laser therapy can be quite expensive when compared to other treatment modalities for burn scars, and while promising, its true usefulness has yet to be conclusively demonstrated. For this reason, our assessing the effects of fractional vascular lasers on burn scars. It has been hypothesized that the fractional vascular lasers work on mature scars to decrease scar formation, and the fractional laser works on scar that is quiescent to promote remodelling. The retexturing/ resurfacing of the laser theoretically can decrease the visibility of the mesh pattern created by meshed split thickness skin graft).

Objective:

To determine the benefit of fractional vascular laser treatment in improving burn scar height, texture, vascularity and pliability in late burn scars.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * living in Winnipeg * burn scar 6-12 months old * Fitzpatrick skin type I-III * thermal burn scar on trunk or extremities Exclusion Criteria: * open wound

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Manitoba Winnipeg Manitoba Recruiting

More University of Manitoba trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01619917 on ClinicalTrials.gov ↗ ← All trials in Canada